Kuraray Medical Transfers Apheresis Business Rights To Kuwasumi Laboratories
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Kuraray Medical agreed to transfer therapeutic apheresis device business rights to Kuwasumi Laboratories this October. The company also plans to transfer the apheresis device manufacturing business to Asahi Chemical Kuraray Medical. The original plan to transfer the whole business to Asahi Chemical was blocked by the Japan Fair Trade Commission in 2006. Kuraray said the negotiation with Asahi Chemical is still undergoing. (Click here for more - Japanese language